Saad Alamri Selected Research

COVID-19

1/2023	Association between the expression of toll-like receptors, cytokines, and homeostatic chemokines in SARS-CoV-2 infection and COVID-19 severity.
11/2022	Analyzing the Difference in the Length of Stay (LOS) in Moderate to Severe COVID-19 Patients Receiving Hydroxychloroquine or Favipiravir.
1/2022	Evaluation of the Levels of Peripheral CD3+, CD4+, and CD8+ T Cells and IgG and IgM Antibodies in COVID-19 Patients at Different Stages of Infection.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Saad Alamri Research Topics

Disease

5	Infections 01/2023 - 04/2020
3	COVID-19 01/2023 - 01/2022
1	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2023
1	Neoplasms (Cancer) 06/2022
1	Corneal Injuries 01/2022
1	Pain (Aches) 01/2022
1	Eye Infections 01/2022
1	Coinfection 01/2022

Drug/Important Bio-Agent (IBA)

2	Immunoglobulin M (IgM)IBA 01/2023 - 01/2022
2	Immunoglobulin G (IgG)IBA 01/2023 - 01/2022
2	AntibodiesIBA 01/2023 - 01/2022
1	Therapeutic UsesIBA 01/2023
1	Proteins (Proteins, Gene)FDA Link 01/2023
1	Messenger RNA (mRNA)IBA 01/2023
1	Toll-Like Receptors (Toll-Like Receptor)IBA 01/2023
1	CytokinesIBA 01/2023
1	ChemokinesIBA 01/2023
1	favipiravirIBA 11/2022
1	Hydroxychloroquine (Plaquenil)FDA LinkGeneric 11/2022
1	Silicon Dioxide (Silica)FDA LinkGeneric 06/2022
1	SilverIBA 06/2022
1	Anti-Bacterial Agents (Antibiotics)IBA 01/2022
1	Chloramphenicol (Chloromycetin)FDA Link 01/2022
1	Clotrimazole (Lotrimin)FDA LinkGeneric 01/2022
1	Fusidic Acid (Fucithalmic)IBA 01/2022
1	Anthocyanins (Anthocyanin)IBA 10/2021
1	ChlorophyllIBA 10/2021
1	Drinking WaterIBA 04/2020

Therapy/Procedure

1	Therapeutics 01/2023
1	Length of Stay 11/2022
1	Antibiotic Prophylaxis 01/2022